- Home
- RGC vs NEWT Comparison
RGC vs NEWT Comparison
Compare RGC & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- NEWT
- Stock Information
- Founded
- RGC 2014
- NEWT 1998
- Country
- RGC Hong Kong
- NEWT United States
- Employees
- RGC N/A
- NEWT N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- NEWT Major Banks
- Sector
- RGC Health Care
- NEWT Finance
- Exchange
- RGC Nasdaq
- NEWT Nasdaq
- Market Cap
- RGC 377.5M
- NEWT 306.7M
- IPO Year
- RGC 2021
- NEWT N/A
- Fundamental
- Price
- RGC $38.01
- NEWT $10.40
- Analyst Decision
- RGC
- NEWT Hold
- Analyst Count
- RGC 0
- NEWT 4
- Target Price
- RGC N/A
- NEWT $14.00
- AVG Volume (30 Days)
- RGC 1.5M
- NEWT 197.1K
- Earning Date
- RGC 07-01-2025
- NEWT 07-28-2025
- Dividend Yield
- RGC N/A
- NEWT 7.32%
- EPS Growth
- RGC N/A
- NEWT 27.62
- EPS
- RGC N/A
- NEWT 1.92
- Revenue
- RGC N/A
- NEWT $352,584,000.00
- Revenue This Year
- RGC N/A
- NEWT N/A
- Revenue Next Year
- RGC N/A
- NEWT $13.51
- P/E Ratio
- RGC N/A
- NEWT $5.39
- Revenue Growth
- RGC N/A
- NEWT 23.06
- 52 Week Low
- RGC $0.08
- NEWT $9.12
- 52 Week High
- RGC $83.60
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- RGC 56.71
- NEWT 45.56
- Support Level
- RGC $15.12
- NEWT $10.25
- Resistance Level
- RGC $83.60
- NEWT $11.34
- Average True Range (ATR)
- RGC 10.44
- NEWT 0.31
- MACD
- RGC 3.76
- NEWT -0.05
- Stochastic Oscillator
- RGC 34.05
- NEWT 25.23
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.